Answers are grounded in this paper and cite their sources.
Three-dimensional (3D) spheroid models provide physiologically relevant systems for investigating drug responses, cell differentiation, and disease mechanisms. Microwell arrays, particularly integrated with well-plate formats, are commonly employed for spheroid generation and assays because they enable dimensional control and high-throughput production. However, existing platforms are often limited by high costs, complex fabrication, or fixed microwell designs, restricting their broader application in drug testing and disease mechanism studies beyond fundamental biology. Here, we present an optimized and versatile integrated microwell-plate platform that enables reproducible, high-throughput generation of spheroids, supporting both monoculture and co-culture configurations in a cost-effective and user-friendly format. The platform reliably produces scalable tumor spheroids, exemplified by U87 MG spheroids that exhibit size-dependent responses to chemotherapeutic drugs. It also enables early differentiation of stem cell-derived neural spheroids production, recapitulating brain morphogenesis using the canonical effects of a glycogen synthase kinase 3 inhibitor patterning. Furthermore, co-culture of neural spheroids with U87 MG aggregates showed density-dependent spheroid formation and revealed tumor-neural cell interactions, including markedly reduced size expansion of neural spheroids at higher tumor cell numbers. This platform provides a scalable and robust tool for 3D culture applications, spanning preclinical drug screening, neural differentiation studies, and investigation of tumor-neural crosstalk.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: